Immunoregulatory effects of human dental pulp-derived stem cells on T cells: comparison of transwell co-culture and mixed lymphocyte reaction systems

References

• Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, . Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood. 2002;99:3838–43.
   PubMed Web of Science ®Google Scholar
• Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation. 2003;75:389–97.
   PubMed Web of Science ®Google Scholar
• Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, . Human mesenchymal stem cells modulate B-cell functions. Blood. 2006;107:367–72.
   PubMed Web of Science ®Google Scholar
• Jiang XX, Zhang Y, Liu B, Zhang SX, Wu Y, Yu XD, . Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood. 2005; 105:4120–6.
   PubMed Web of Science ®Google Scholar
• English K, Barry FP, Mahon BP. Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation. Immunol Lett. 2008;115:50–8.
   PubMed Web of Science ®Google Scholar
• Spaggiari GM, Capobianco A, Becchetti S, Mingari MC, Moretta L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood. 2006;107:1484–90.
   PubMed Web of Science ®Google Scholar
• Casiraghi F, Azzollini N, Cassis P, Imberti B, Morigi M, Cugini D, . Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. J Immunol. 2008;181:3933–46.
   PubMed Web of Science ®Google Scholar
• Van den Brink MR, Burakoff SJ. Cytolytic pathways in haematopoietic stem-cell transplantation. Nat Rev Immunol. 2002;2:273–81.
   PubMed Web of Science ®Google Scholar
• Ringden O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lönnies H, . Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation. 2006;81:1390–7.
   PubMed Web of Science ®Google Scholar
• Garcia-Olmo D, Garcia-Arranz M, Herreros D, Pascual I, Peiro C, Rodriguez-Montes JA. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stems cell transplantation. Dis Colon Rectum. 2005;48:1416–23.
   PubMed Web of Science ®Google Scholar
• Pierdomenico L, Bonsi L, Calvitti M, Rondelli D, Arpinati M, Chirumbolo G, . Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp. Transplantation. 2005;80:836–42.
   PubMed Web of Science ®Google Scholar
• Inoue S, Popp FC, Koehl GE, Piso P, Schlitt HJ, Geissler EK, . Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation. 2006; 81:1589–95.
   PubMed Web of Science ®Google Scholar
• Yoo KH, Jang IK, Lee MW, Kim HE, Yang MS, Eom Y, . Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell Immunol. 2009;259:150–6.
   PubMed Web of Science ®Google Scholar
• Valencic E, Piscianz E, Andolina M, Ventura A, Tommasini A. The immunosuppressive effect of Wharton's jelly stromal cells depends on the timing of their licensing and on lymphocyte activation. Cytotherapy. 2010;12:154–60.
   Web of Science ®Google Scholar
• Najar M, Rouas R, Raicevic G, Boufker HI, Lewalle P, Meuleman N, . Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6. Cytotherapy. 2009;11:570–83.
   PubMed Web of Science ®Google Scholar
• Bian L, Guo ZK, Wang HX, Wang JS, Wang H, Li QF, . In vitro and in vivo immunosuppressive characteristics of hepatocyte growth factor-modified murine mesenchymal stem cells. In Vivo. 2009;23:21–7.
   PubMed Web of Science ®Google Scholar
• Mourez RR, Francois M, Boivin MN, Stagg J, Galipeau J. Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density. J Immunol. 2007;179:1549–58.
   Google Scholar
• Djouad F, Charbonnier LM, Bouffi C, Louis-Plence P, Bony C, Apparailly F, . Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells. 2007;25:2025–32.
   PubMed Web of Science ®Google Scholar
• English K, Ryan JM, Tobin L, Murphy MJ, Barry FP, Mahon BP. Cell contact, prostaglandin E2 and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+ CD25high forkhead box P3+regulatory T cells. Clin Exp Immunol. 2009;156:149–60.
   PubMed Web of Science ®Google Scholar
• Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, . Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008;2:141–50.
   PubMed Web of Science ®Google Scholar
• Selmani Z, Naji A, Zidi I, Favier B, Gaiffe E, Obert L, . Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25high FOXP3+ regulatory T cells. Stem Cells. 2008;26:212–22.
   PubMed Web of Science ®Google Scholar
• Zohair S, Abderrahim N, Emilie G, Laurent O, Pierre T, Rouas NF, . HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells. Transplantation. 2009;87:62–6.
   Google Scholar
• Kögler G, Radke TF, Lefort A, Sensken S, Fischer J, Sorg RV, . Cytokine production and hematopoiesis supporting activity of cord blood-derived unrestricted somatic stem cells. Exp Hematol. 2005;33:573–83.
   PubMed Web of Science ®Google Scholar
• Ren G, Zhao X, Zhang L, Zhang J, L'Huillier A, Ling W, . Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J Immunol. 2010;184:2321–8.
   PubMed Web of Science ®Google Scholar
• Sordi V, Malosio ML, Marchesi F, Mercalli A, Melzi R, Giordano T, . Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood. 2005;106:419–27.
   PubMed Web of Science ®Google Scholar
• Glennie S, Soeiro I, Dyson PJ, Lam EW, Dazzi F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood. 2005;105:2821–7.
   PubMed Web of Science ®Google Scholar
• Beyth S, Borovsky Z, Mevorach D, Liebergall M, Gazit Z, Aslan H, . Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood. 2005;105:2214–19.
   PubMed Web of Science ®Google Scholar
• Bifari F, Lisi V, Mimiola E, Pasini A, Krampera M. Immune modulation by mesenchymal stem cells. Trans Med Hemother. 2008;35:194–204.
   PubMed Web of Science ®Google Scholar
• Jiang XX, Zhang Y, Liu B, Zhang SX, Wu Y, Yu XD, . Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood. 2005;105:4120–6.
   PubMed Web of Science ®Google Scholar
• Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN, Papamichail M. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells. 2006;24: 74–85.
   PubMed Web of Science ®Google Scholar
• Karaöz E, Doğan BN, Aksoy A, Gacar G, Akyüz S, Ayhan S, . Isolation and characterization of dental pulp stem cells from natal teeth. Histochem Cell Biol. 2010;133: 95–112.
   PubMed Web of Science ®Google Scholar
• Karaoz E, Ayhan S, Gacar G, Aksoy A, Duruksu G, Okçu A, . Isolation and characterization of stem cells from pancreatic islet: pluripotency, differentiation potential and ultrastructural characteristics. Cytotherapy. 2010;12: 288–302.
   PubMed Web of Science ®Google Scholar
• Karaoz E, Aksoy A, Ayhan S, Sarıboyacı AE, Kaymaz F, Kasap K. Characterization of mesenchymal stem cells from rat bone marrow: ultrastructural properties, differentiation potential and immunophenotypic markers. Histochem Cell Biol. 2009;132:533–46.
   PubMed Web of Science ®Google Scholar
• Karaoz E, Genç ZS, Demircan PÇ, Aksoy A, Duruksu G. Protection of rat pancreatic islet function and viability by coculture with rat bone-marrow derived mesenchymal stem cells. Cell Death Dis. 2010;1:1–8.
   Google Scholar
• Karaöz E, Patır A, Sarıboyacı AE, Okcu A, Köktürk S, Gacar G, Demircan PC, Kasap M, Seymen F. Characterization and differentiation of dental pulp and PDL stem cells. Continental European Division (CED) of the International Association for Dental Research (IADR) for 4th Meeting of the Pan European Federation in London. England; 2008. 228.
   Google Scholar
• Aksoy A, Ayhan S, Okcu A, Karaoz E. In vitro differentiation potential of mesenchymal stem cells derived from natal, wisdom, deciduous teeth dental pulp and human bone marrow: a comparative study. Haematologica. 15th Congress of the European Hematology Association Barcelona, 2010. 444–5.
   Google Scholar
• Sensebé L, Krampera M, Schrezenmeier H, Bourin P, Giordano R. Mesenchymal stem cells for clinical application Vox Sang. 2010;98:93–107.
   Google Scholar
• Yagi H, Soto-Gutierrez A, Parekkadan B, Kitagawa Y, Tompkins RG, Kobayashi N, . Mesenchymal stem cells. Mechanisms of immunomodulation and homing. Cell Transplant. 2010;19:667–79.
   PubMed Web of Science ®Google Scholar
• Demircan PC, Gacar G, Eker A, Karaöz E. Study on the immuno-suppressive characteristics of human dental pulp derived mesenchymal stem cells on T cells in-vitro: initial study outputs. Haematologica. 2010;95:652.
   Google Scholar
• Demircan PC, Sariboyaci AE, Gacar G, Karaöz E. Comparative study of immunosuppressive characteristics of human dental pulp derived mesenchymal stem cells on T cells in-vitro. University of Leipzig, 5th World Congress on Preventative and Regenerative Medicine, Hannover, Germany; 2010. 60.
   Google Scholar
• Bocelli-Tyndall C, Bracci L, Schaeren S, Feder-Mengus C, Barbero A, Tyndall A, . Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro proliferation of lymphocytes stimulated by interleukins 2, 7 and 15 Ann Rheum Dis. 2009;68:1352–9.
   Google Scholar
• Cutler AJ, Limbani V, Girdlestone J, Navarrete CV. Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress T cell proliferation. J Immunol. 2010;185:6617–23.
   PubMed Web of Science ®Google Scholar
• Li C, Zhang W, Jiang X, Ning M. Human-placenta-derived mesenchymal stem cells inhibit proliferation and function of allogeneic immune cells. Cell Tissue Res. 2007;330:437–46.
   PubMed Web of Science ®Google Scholar
• De Coppi P, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC, Perin L, . Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 2007;25:100–6.
   PubMed Web of Science ®Google Scholar
• Prasanna SJ, Gopalakrishnan D, Shankar SR, Vasandan AB. Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS One. 2010;5:1–16.
   Google Scholar
• Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, Andreini A, . Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells. 2006;24:386–98.
   PubMed Web of Science ®Google Scholar
• Nasef A, Mathieu N, Chapel A, Frick J, Francois S, Mazurier C, . Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G. Transplantation. 2007;84:231–7.
   PubMed Web of Science ®Google Scholar
• Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy: review of a new approach. Pharmacol Rev. 2003;55:241–69.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155:1151–64.
   PubMed Web of Science ®Google Scholar
• Djouad F, Fritz V, Apparailly F, Louis-Plence P, Bony C, Sany J, . Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum. 2005;52: 1595–603.
   PubMed Web of Science ®Google Scholar
• Franzke A, Geffers R, Hunger JK, Pförtner S, Piao W, Ivanyi P, . Identification of novel regulators in T-cell differentiation of aplastic anemia patients. BMC Genomics. 2006;7:1–11.
   Google Scholar
• Robertson MJ. Role of chemokines in the biology of natural killer cells. J Leukoc Biol. 2002;71:173–83.
   PubMed Web of Science ®Google Scholar
• Rasmusson I, Ringden O, Sundberg B, Le Blanc K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation. 2003;76:1208–13.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Rasmusson I, Götherström C, Seidel C, Sundberg B, Sundin M, . Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scand J Immunol. 2004;60:307–15.
   PubMed Web of Science ®Google Scholar
• Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, Nadaf S, . Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med. 1996;2:1096–103.
   PubMed Web of Science ®Google Scholar
• Gabrilovich D, Ishida T, Oyama T, Ran S, Kravtsov V, Nadaf S, . Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood.1998;92:4150–66.
   PubMed Web of Science ®Google Scholar
• Plumas J, Chaperot L, Richard MJ, Molens JP, Bensa JC, Favrot MC. Mesenchymal stem cells induce apoptosis of activated T cells. Leukemia. 2005;19:1597–604.
   PubMed Web of Science ®Google Scholar
• Suva D, Passweg J, Arnaudeau S, Hoffmeyer P, Kındler V. In vitro activated human T lymphocytes very efficiently attach to allogenic multipotent mesenchymal stromal cells and transmigrate under them. Cell Physiol. 2007;214:588–94.
   Google Scholar
• Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, . Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med. 2002;8:500–8.
   PubMed Web of Science ®Google Scholar
• Charo IF, Peters W. Chemokine receptor 2 (CCR2) in atherosclerosis, infectious diseases, and regulation of T-cell polarization. Microcirculation. 2003;10:259–64.
   Web of Science ®Google Scholar
• Hultqvist M, Olofsson P, Holmberg J, Backstrom BT, Tordsson J, Holmdahl R. Enhanced autoimmunity, arthritis and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc Natl Acad Sci USA. 2004;101:12646–51.
   PubMed Web of Science ®Google Scholar
• Yao Z, Fanslow WC, Seldin MF, Rousseau AM, Painter SL, Comeau MR, . Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity. 1995;3:811–21.
   PubMed Web of Science ®Google Scholar
• Ghannam S, Pène J, Torcy-Moquet G, Jorgensen C, Yssel H. Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. J Immunol. 2010;18:302–12.
   Google Scholar